NGS 샘플 조제 시장 : 제품, 워크플로우, 기술, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The NGS Sample Preparation Market was valued at USD 2.40 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 16.01%, to USD 6.80 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation encompasses all necessary steps to prepare nucleic acids for sequencing, including extraction, purification, fragmentation, and library construction. This segment is indispensable to the overall NGS process, as it ensures sample quality and the accuracy of downstream results, facilitating applications in genomic research, medical diagnostics, and personalized medicine. With a rising demand in clinical diagnostics, infectious disease research, and cancer genomics, the NGS sample preparation market is witnessing significant growth. Key growth drivers include technological advancements delivering higher throughput and accuracy, a surge in genomic research, and the decreasing cost of sequencing. Additionally, the integration of artificial intelligence and automation in sample preparation processes presents lucrative opportunities for market players to enhance efficiency and reduce errors. However, market growth faces challenges such as the high initial setup cost, regulatory complexities, and the need for highly skilled personnel to run sophisticated NGS platforms. Small and medium-sized enterprises may find these barriers particularly prohibitive. Despite these challenges, innovation remains robust, with potential research areas including the development of standardized, user-friendly kits and consumables capable of handling diverse samples with greater efficiency. Companies are encouraged to focus on partnerships and collaborations to expand technological capabilities and integrate innovative approaches such as lab-on-a-chip systems for microfluidic sample preparation. Insight into the market reveals a competitive yet rapidly evolving landscape where staying at the forefront of technology and offering customizable and cost-effective solutions are vital for business growth. The nature of the NGS sample preparation market is dynamic, driven by continuous technological breakthroughs and an expanding array of applications, suggesting a promising future with opportunities for stakeholders willing to adapt and innovate accordingly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS Sample Preparation Market

The NGS Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious diseases and rising need for early disease diagnosis
  • Favorable investment landscape in NGS for the research and development of new treatments
  • Emerging use of NGS sequencing technology in agriculture for sustainable productivity
• Market Restraints
  • High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
• Market Opportunities
  • Technological advancement in NGS sample preparation platforms
  • Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
• Market Challenges
  • Limited availability of skilled professionals in medium and small size laboratories

Porter's Five Forces: A Strategic Tool for Navigating the NGS Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS Sample Preparation Market

A detailed market share analysis in the NGS Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS Sample Preparation Market

A strategic analysis of the NGS Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Reagents & Consumables and Workstations.
• Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES).
• Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing.
• Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics.
• Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
    • 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
    • 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in NGS sample preparation platforms
    • 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. NGS Sample Preparation Market, by Product

• 6.1. Introduction
• 6.2. Reagents & Consumables
• 6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

• 7.1. Introduction
• 7.2. DNA
  • 7.2.1. Human Whole Genome Sequencing (WGS)
  • 7.2.2. Targeted Sequencing
  • 7.2.3. Whole Exome Sequencing (WES)
• 7.3. Library Preparation
• 7.4. Quality Control
• 7.5. RNA
  • 7.5.1. Gene Expression Analysis
  • 7.5.2. Whole Transcriptome Sequencing
• 7.6. Target Enrichment
  • 7.6.1. Targeted Seq
  • 7.6.2. WES
  • 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

• 8.1. Introduction
• 8.2. Ion Semiconductor Sequencing
• 8.3. Nanopore Sequencing
• 8.4. Sequencing by Synthesis (SBS)
• 8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

• 9.1. Introduction
• 9.2. Agricultural & Animal Research
• 9.3. Disease Diagnostics
  • 9.3.1. Cancer Diagnostics
  • 9.3.2. Infectious Disease Diagnostics
  • 9.3.3. Reproductive Health Diagnostics
• 9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

• 10.1. Introduction
• 10.2. Academic Institutes and Research Centers
• 10.3. Hospitals & Clinics
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Agilent enhances user experience in NGS sample preparation workflow
  • 14.3.2. INTEGRA Biosciences Acquires Miroculus
  • 14.3.3. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
  • 14.3.4. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
  • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
  • 14.3.6. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
  • 14.3.7. NGS KAPA Target Enrichment Product Launch
  • 14.3.8. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
  • 14.3.9. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs
  • 14.3.10. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied Biological Materials Inc.
• 3. Aurora Biomed Inc.
• 4. Beckman Coulter by Danaher Corporation
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. BioDynami
• 8. Eppendorf SE
• 9. Eurofins Genomics LLC
• 10. F. Hoffmann-La Roche Ltd.
• 11. FORMULATRIX, Inc.
• 12. Illumina, Inc.
• 13. Integrated DNA Technologies, Inc.
• 14. Macrogen Inc.
• 15. Magen Biotechnology Co., Ltd.
• 16. MCLAB
• 17. Merck KGaA
• 18. New England Biolabs, Inc.
• 19. Novogene Co., Ltd.
• 20. Oxford Nanopore Technologies PLC
• 21. PerkinElmer Inc.
• 22. Promega Corporation
• 23. Psomagen, Inc.
• 24. Qiagen N.V.
• 25. SPT Labtech Ltd
• 26. Standard BioTools Inc.
• 27. Sysmex Corporation
• 28. Takara Bio Inc.
• 29. Tecan Trading AG
• 30. Thermo Fisher Scientific Inc.
• 31. Twist Bioscience Corporation
• 32. Zymo Research Corporation